Aiming at appropriate preparation for the future development of individualized and regenerative medicine (in particular, gene, stem cell and tissue engineering therapies), the Health Intervention and Technology Assessment (HITAP) program has agreed to conduct a study to provide an insight on elements necessary for national policymaking in Thailand.

Australia developed the Life-Saving Drugs Program (LSDP) in 1995 to complement the Pharmaceutical Benefits Scheme (PBS), expanding access to high-cost drugs for rare diseases (DRD). This program, funded and administered by the Department of Health and Aged Care, permitted sponsors (often pharmaceuti

Thailand spent 440,023 million baht on healthcare in response to the COVID-19 pandemic in 2020–2022, of which 257,892 million baht went toward COVID-19 tests, treatments, and vaccination services. In addition to having higher hospital reserves than in the pre-pandemic period, private hospital

The Cancer Drug Fund (CDF) is a dedicated source of funding in England for increasing patient access to high-cost cancer drugs, with a fixed budget of £340 million per year, operating since 2016. The CDF follows the appraisal by the National Institute of Health and Care Excellence (NICE) whic

This policy brief provides a summary of a recent review of the definition of rare diseases, high cost and how HTA has been used in the case of rare diseases in seven countries. The countries were purposively selected based on them having established HTA policies and availability of resources in the

Open data is widely recognized as valuable, especially during the COVID-19 pandemic, highlighting the need for up-to-date information systems, leading all sectors to acknowledge its significance in enhancing efficiency, fairness, and societal development. These open data movements observed during

Familial Hypercholesterolemia (FH) is a genetic disorder characterized by elevated cholesterol levels, significantly increasing the risk of heart disease. Early detection through genetic screening can play a crucial role in preventing serious health outcomes. This study marks the first global eco

– The pharmaceutical industry is a significant emitter of carbon emissions, which accelerates climate change and directly affects human health and health systems. – The safety and efficacy profiles of intravenous (IV) and oral paracetamol for patients undergoing surgeries are comparable. – Swi

This study is a development oriented research. The data is collected by participant observation, brainstorming with experts, and a questionnaire asking opinions and the satisfaction from stakeholders attending the meeting of “the prioritization of research topics” on January 22nd, 2010. There was a total of 120 research topics proposed by 66 ag

Economic evaluation of HLA-B*1502 screening for preventing carbamazepine- induced Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) is prioritized by stakeholders under ‘Research for development of health benefit package under universal coverage scheme’. The study carried out an evidence to inform the Subcommittee for Developm